Bio-implants Market Growth Analysis By Top Key Players: Abbott Laboratories, Boston Scientific Corporation, Dentsply Sirona, Johnson & Johnson, Medtronic, Smith & Nephew, Wright Medical Group & Zimmer Biomet Holdings Inc.

The Global Bioimplants Market was valued at $77,738 million in 2016, and is estimated to reach $124,154 million by 2023, with a CAGR of 6.9% from 2017 to 2023. Bioimplants are surgically implanted to replace or support any damaged body organs to enhance function of any body organ. The major factors that drive the growth of the global bioimplants market include rise in prevalence of chronic diseases coupled with the rapidly aging population. Furthermore, increased awareness and technological advancements in bioimplant further propel the market growth. However, high implantation cost and lack of expertise are some of the factors restrict the market growth.

Download PDF Report Sample @ https://www.alliedmarketresearch.com/request-sample/4652

High Incidence of Chronic Conditions with Increasing Age

According to the National Institutes of Health report, it is estimated that 27% of the Japanese, 16% of the U.S., 24% of the UK, 17% of the Russian, and 14% of Chinese the population will be above 65 years of age by 2020. With age there is an increase in incidence of chronic diseases such as cardiovascular disease, neuropathic disorders, old age-related trauma, and osteoarthritis. For instance, according to the American Heart Association, in 2013 in the U.S., 70.2% of men and 70.9% of women in the range of age 60-79 years have cardiovascular disorders. Moreover, it is been predicted by World Health Organization that there will be an increase of 50% in cardiovascular disorders in China between 2010 and 2030 based on an increase in aging population.

Bioimplant are devices of human or animal origin used to replace a missing natural body structure, support an injured biological part, or improve an existing biological structure. The major factors that contribute to the market growth include increase in geriatric population, rapid technological advancements, rise in incidence of chronic diseases, surge in adoption of advanced treatment devices, and growth in awareness regarding both the disease and treatment devices available in the market. However, the stringent approval procedure of the bioimplant is expected to impede the market growth. In addition, significant unmet need in the emerging nations provides a lucrative opportunity for the market.

The orthopedic bioimplant segment generated the maximum revenue, accounting for nearly 40% of the global digital bioimplant market in 2016. On the other hand, dental bioimplant segment is expected to witness the highest CAGR during the forecast period.

By material, the metallic biomaterial segment is expected to dominate the market, accounting for nearly two-thirds share in 2023. On the other hand, the polymeric biomaterials segment is estimated to register the highest CAGR during the forecast period.

The North America market is projected to dominate the global bioimplant market in terms of revenue during the forecast period. This is majorly due to the increase in technological development and rise in incidence of cardiac, neuro, and spinal disorders. The Asia-Pacific market is expected to grow at the highest CAGR of 8.7% during the forecast period, owing to rise in awareness about the use of bio implants in the healthcare industry and surge in expenditures in emerging markets (such as India and China) to cater to the unmet medical needs.

The major companies profiled in the report are

- Abbott Laboratories (St. Jude Medical, Inc.),
- Boston Scientific Corporation,
- Dentsply Sirona Inc.,
- Johnson & Johnson (Ethicon, Inc.),
- Medtronic Plc,
- Smith & Nephew Plc,
- Stryker Corporation,
- Victrex Plc. (Invibio Ltd.),
- Wright Medical Group N.V., and Zimmer Biomet Holdings Inc.

Get Customized Report @ https://www.alliedmarketresearch.com/request-for-customization/4652

Table Of Content


Chapter: 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2: EXECUTIVE SUMMARY

2.1. Key findings of the study
2.2. CXO perspective

Chapter: 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top winning strategies
3.2.2. Top investment pockets

3.3. Top player positioning, 2016
3.4. Market dynamics

3.4.1. Drivers

3.4.1.1. Growth in elderly population and rise in prevalence of chronic diseases
3.4.1.2. Technological advancements in the field of bioimplant
3.4.1.3. Global rise in acceptance of bioimplant
3.4.1.4. Better insurance and reimbursement
3.4.1.5. Increase in government focus on funding R&D initiatives

3.4.2. Restraints

3.4.2.1. High cost of treatment associated with bioimplant
3.4.2.2. Stringent approval process

3.4.3. Opportunities

3.4.3.1. Huge market opportunities in the APAC region and developing countries
3.4.3.2. Increase in development of minimally invasive and non-surgical procedures
3.4.3.3. Rise in awareness amongst patients and increasing preference for a better quality of life

3.4.4. Impact analysis

Access Full Summery @ https://www.alliedmarketresearch.com/press-release/bioimplants-market.html

About Us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free: +1-800-792-5285
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: www.alliedmarketresearch.com

This release was published on openPR.